Ad is loading...
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
WIESX
Price
$17.36
Change
-$0.20 (-1.14%)
Updated
Nov 15 closing price
Ad is loading...

FNWFX vs WIESX

Header iconFNWFX vs WIESX Comparison
Open Charts FNWFX vs WIESXBanner chart's image
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Wasatch Emerging Markets Select Instl
Price$17.36
Change-$0.20 (-1.14%)
VolumeN/A
CapitalizationN/A
FNWFX vs WIESX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. WIESX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and WIESX is a StrongSell.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. WIESX (405M). FNWFX pays higher dividends than WIESX: FNWFX (1.56) vs WIESX (0.00). FNWFX was incepted earlier than WIESX: FNWFX (8 years) vs WIESX (12 years). FNWFX is a more actively managed with annual turnover of: 32.00 vs. WIESX (14.00). WIESX has a lower initial minimum investment than FNWFX: WIESX (100000) vs FNWFX (1000000). WIESX (12.14) and FNWFX (11.59) have marching annual gain over last year. WIESX return over 5 years is better than : 41.48 vs. FNWFX (17.23).
FNWFXWIESXFNWFX / WIESX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years12 years-
Gain YTD7.1472.479288%
Front LoadN/AN/A-
Min. Initial Investment10000001000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B405M15,037%
Annual Yield % from dividends1.560.00-
Returns for 1 year11.5912.1495%
Returns for 3 years-14.49-29.3449%
Returns for 5 years17.2341.4842%
Returns for 10 yearsN/A63.16-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology